Insider Trades
Common-stock transactions that officers, directors and 10% owners of healthcare companies report to the SEC on Form 4, from 2006 to today, newest first.
Insider filings are public records and are not a recommendation.
Results
25+ transactions, newest first
| Date | Insider | Relationship | Company | Transaction | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Banjak Marc | Chief Legal Officer | iBio, Inc.IBIO | BuyP · Open-market or private purchase | 1,434 | $1.76 | $2,523.84 | 25,000Direct | Form 4 filed 27 Mar 2026, on sec.gov (opens in a new tab)Filed 27 Mar 2026 | |
| Banjak Marc | Chief Legal Officer | iBio, Inc.IBIO | BuyP · Open-market or private purchase | 12,500 | $1.64 | $20,500 | 23,566Direct | Form 4 filed 27 Mar 2026, on sec.gov (opens in a new tab)Filed 27 Mar 2026 | |
| Brenner Martin | Director, See Remarks | iBio, Inc.IBIO | BuyP · Open-market or private purchase | 12,336 | $2.02 | $24,918.72 | 30,652Direct | Form 4 filed 23 Mar 2026, on sec.gov (opens in a new tab)Filed 23 Mar 2026 | |
| Duran Felipe | Chief Financial Officer | iBio, Inc.IBIO | BuyP · Open-market or private purchase | 24,835 | $2.02 | $50,166.70 | 35,974Direct | Form 4 filed 23 Mar 2026, on sec.gov (opens in a new tab)Filed 23 Mar 2026 | |
| Arkowitz David | Director | iBio, Inc.IBIO | BuyP · Open-market or private purchase | 18,382 | $2.72 | $49,999.04 | 18,382Direct | Form 4 filed 13 Jan 2025, on sec.gov (opens in a new tab)Filed 13 Jan 2025 | |
| Brenner Martin | Director, See Remarks | iBio, Inc.IBIO | BuyP · Open-market or private purchase | 9,191 | $2.72 | $24,999.52 | 18,316Direct | Form 4 filed 13 Jan 2025, on sec.gov (opens in a new tab)Filed 13 Jan 2025 | |
| Duran Felipe | Chief Financial Officer | iBio, Inc.IBIO | BuyP · Open-market or private purchase | 9,191 | $2.72 | $24,999.52 | 11,139Direct | Form 4 filed 13 Jan 2025, on sec.gov (opens in a new tab)Filed 13 Jan 2025 | |
| Sender Gary | Director | iBio, Inc.IBIO | BuyP · Open-market or private purchase | 9,191 | $2.72 | $24,999.52 | 9,191Direct | Form 4 filed 13 Jan 2025, on sec.gov (opens in a new tab)Filed 13 Jan 2025 | |
| Parada Antonio Bernardino Guimaraes | Director | iBio, Inc.IBIO | BuyP · Open-market or private purchase | 183,823 | $2.72 | $499,998.56 | 183,823Indirect, See Footnotes | Form 4 filed 13 Jan 2025, on sec.gov (opens in a new tab)Filed 13 Jan 2025 | |
| Banjak Marc | Chief Legal Officer | iBio, Inc.IBIO | BuyP · Open-market or private purchase | 9,191 | $2.72 | $24,999.52 | 11,066Direct | Form 4 filed 13 Jan 2025, on sec.gov (opens in a new tab)Filed 13 Jan 2025 | |
| Clark William D | Director | iBio, Inc.IBIO | BuyP · Open-market or private purchase | 1,838 | $2.72 | $4,999.36 | 1,838Direct | Form 4 filed 13 Jan 2025, on sec.gov (opens in a new tab)Filed 13 Jan 2025 | |
| Brenner Martin | See Remarks | iBio, Inc.IBIO | SellS · Open-market or private sale | 4,881 | $0.27 | $1,317.87 | 182,502Direct | Form 4 filed 3 Nov 2023, on sec.gov (opens in a new tab)Filed 3 Nov 2023 | |
| Brenner Martin | See Remarks | iBio, Inc.IBIO | SellS · Open-market or private sale | 5,267 | $0.30 | $1,580.10 | 187,383Direct | Form 4 filed 5 Oct 2023, on sec.gov (opens in a new tab)Filed 5 Oct 2023 | |
| Brenner Martin | See Remarks | iBio, Inc.IBIO | SellS · Open-market or private sale | 4,215 | $0.31 | $1,306.65 | 192,650Direct | Form 4 filed 3 Oct 2023, on sec.gov (opens in a new tab)Filed 3 Oct 2023 | |
| Brenner Martin | See Remarks | iBio, Inc.IBIO | SellS · Open-market or private sale | 5,011 | $0.31 | $1,553.41 | 196,865Direct | Form 4 filed 30 Aug 2023, on sec.gov (opens in a new tab)Filed 30 Aug 2023 | |
| Brenner Martin | See Remarks | iBio, Inc.IBIO | SellS · Open-market or private sale | 35 | $0.51 | $17.85 | 201,876Direct | Form 4 filed 28 Jul 2023, on sec.gov (opens in a new tab)Filed 28 Jul 2023 | |
| Brenner Martin | See Remarks | iBio, Inc.IBIO | SellS · Open-market or private sale | 4,480 | $0.51 | $2,284.80 | 201,911Direct | Form 4 filed 28 Jul 2023, on sec.gov (opens in a new tab)Filed 28 Jul 2023 | |
| Brenner Martin | See Remarks | iBio, Inc.IBIO | SellS · Open-market or private sale | 47,020 | $0.59 | $27,741.80 | 206,391Direct | Form 4 filed 13 Jul 2023, on sec.gov (opens in a new tab)Filed 13 Jul 2023 | |
| Brenner Martin | See Remarks | iBio, Inc.IBIO | OtherA · Grant or award from the company | 75,833 | $0.00 | $0 | 253,411Direct | Form 4 filed 27 Jun 2023, on sec.gov (opens in a new tab)Filed 27 Jun 2023 | |
| Brenner Martin | See Remarks | iBio, Inc.IBIO | OtherD · Sale or transfer back to the company | 75,833 | $0.00 | $0 | 177,578Direct | Form 4 filed 27 Jun 2023, on sec.gov (opens in a new tab)Filed 27 Jun 2023 | |
| Brenner Martin | See Remarks | iBio, Inc.IBIO | SellS · Open-market or private sale | 100 | $0.68 | $68 | 253,411Direct | Form 4 filed 22 Jun 2023, on sec.gov (opens in a new tab)Filed 22 Jun 2023 | |
| Brenner Martin | See Remarks | iBio, Inc.IBIO | SellS · Open-market or private sale | 225 | $0.69 | $155.25 | 253,511Direct | Form 4 filed 22 Jun 2023, on sec.gov (opens in a new tab)Filed 22 Jun 2023 | |
| Brenner Martin | See Remarks | iBio, Inc.IBIO | SellS · Open-market or private sale | 3,859 | $0.68 | $2,624.12 | 253,736Direct | Form 4 filed 22 Jun 2023, on sec.gov (opens in a new tab)Filed 22 Jun 2023 | |
| Brenner Martin | See Remarks | iBio, Inc.IBIO | SellS · Open-market or private sale | 24 | $0.95 | $22.80 | 257,595Direct | Form 4 filed 24 May 2023, on sec.gov (opens in a new tab)Filed 24 May 2023 | |
| Brenner Martin | See Remarks | iBio, Inc.IBIO | SellS · Open-market or private sale | 4,158 | $0.94 | $3,908.52 | 257,619Direct | Form 4 filed 24 May 2023, on sec.gov (opens in a new tab)Filed 24 May 2023 |
Source: SEC EDGAR Form 4 filings and the SEC Insider Transactions Data Sets (2006 onward). Each row links to its Form 4 filing. Values are shares times the reported price. Nothing here is investment advice.